Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells (2011)
- Authors:
- USP affiliated authors: SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP ; CARLOTTI JUNIOR, CARLOS GILBERTO - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS (TRATAMENTO); FÁRMACOS; PROTEÍNAS; APOPTOSE
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Pediatric Blood & Cancer
- ISSN: 1545-5009
- Volume/Número/Paginação/Ano: v. 57, n. 5, p. 718, res. O044, 2011
- Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP)
-
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 23 abr. 2024. , 2011 -
APA
Castro-Gamero, A. M., Borges, K. S., Moreno, D. A., Carlotti Júnior, C. G., Scridelli, C. A., & Tone, L. G. (2011). Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 abr. 23 ] -
Vancouver
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 abr. 23 ] - Differential expression of MST2 and MST4 among the molecular subgroups of medulloblastoma
- Abnormal methylation at histone desacetilase 5(HDAC5) gene in gliomas
- Inibição do crescimento e redução da capacidade clonogênica em linhagens celulares de glioblastomas pediátricos e adultos através do DHMEQ
- Acute lymphoblastic leukemia analyzed by comparative genome hybridization(CGH)
- mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia, low expression levels associated with a higher risk of toxic death
- microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis
- Decreased expression of BATF2 is significantly associatedwith poor prognosis in childhood medulloblastoma
- Analysis of molecular pathways by Rnaseq following GDF15 knockdown in paediatric and adult glioblastoma cell lines
- Differential microRNA profiling in pediatric pilocytic astrocytoma and non-neoplastic white matter samples
- Inhibition of carbonic anhydrases (CA) 9 and 12 by indisulam shows significant antiproliferative effects on pediatric and adult glioblastoma cell lines
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
